ENLUXO
Live / Applied — Fourth extension granted (statement of use) (as of 11 Jul 2025)
What this means for you
Not registered yet, but its 17 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97463153
- Mark type
- Stylized text
- Filed
- 17 Jun 2022
- Published for opposition
- 23 May 2023
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical anti-allergic preparations and substances; vaccines
Owner
- JOHNSON & JOHNSON, New Brunswick, NJ, US
- JOHNSON & JOHNSON, New Brunswick, NJ, US
Prosecution history
- 12 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jul 2025 — SOU EXTENSION 4 GRANTED
- 11 Jul 2025 — SOU EXTENSION 4 FILED
- 11 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jan 2025 — SOU EXTENSION 3 GRANTED
- 06 Jan 2025 — SOU EXTENSION 3 FILED
- 06 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2024 — SOU EXTENSION 2 GRANTED
- 09 Jul 2024 — SOU EXTENSION 2 FILED
- 09 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 10 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jan 2024 — SOU EXTENSION 1 GRANTED